添加微信 添加微信
添加微信
首页: 全球医药政策

韩国-LSK Global PS

时间:2021-10-21 15:19:25 来源:康安医药咨询 作者:康安医药咨询

Since March 2000, when LSK Global PS kicked off its business, LSK Global PS has established its position as a one-stop, full-service CRO encompassing all of the major areas of clinical research, i.e. registration trials from phase I to III, investigator-sponsored clinical studies, post-registration studies such as phase IV studies, PMS studies, observational studies, etc., and consulting services for new drug development. As of June 2018, we have conducted about 1027 clinical studies so far, including about 585 registration trials and about 124 global clinical studies.

Phone: 82.2, .546.1008 Fax: 02., 584., 9008 E-mail: information@lskglobal.com
Web: http://www.lskglobal.com
Add:97 Toegye-Ro, Coryo Daeyungak Tower, 16TH Fl., Jung-Gu, Seoul 04535 Korea

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章